Results 161 to 170 of about 6,393 (198)
Some of the next articles are maybe not open access.
Mucocutaneous Leishmaniasis and HIV
Dermatology, 2009Mucocutaneous leishmaniasis is a rare disease in Europe. Relapses after treatment are more frequent than in visceral leishmaniasis. HIV patients infected by Leishmania have frequently visceral involvement, and responses to treatment are poor. Mucocutaneous leishmaniasis in HIV-infected patients has rarely been reported.
E S, Miralles +5 more
openaire +2 more sources
American Mucocutaneous Leishmaniasis
Southern Medical Journal, 1977Presented is a well-documented, autochthonous case of mucocutaneous leishmaniasis, a protozoan disease endemic to Asia, Africa, Southern Europe, South America, and Central America, which until recently was not found in North America. Diagnosis is made by positive culture on NNN media, positive serodiagnosis, positive Montenegro skin test, the presence ...
D, Barlow +3 more
openaire +2 more sources
Imported mucocutaneous leishmaniasis
Clinical and Experimental Dermatology, 1996We report a case of mucocutaneous leishmaniasis in a otherwise fit Caucasian man who had traveled in an endemic area. Initial tissue microscopy failed to identify the causative organism, which was only determined by subsequent culture as Leishmania braziliensis.
J L, Rosbotham +4 more
openaire +2 more sources
Mucocutaneous leishmaniasis as presentation of HIV infection in Sardinia, insular Italy
Leishmaniasis is endemic in Sardinia but only cutaneous and visceral cases have been reported to date. We report a case of mucocutaneous leishmaniasis as presentation of HIV infection in a Sardinian patient who had never visited endemic areas ...
Giordano Madeddu +2 more
exaly +2 more sources
Deforming Mucocutaneous Leishmaniasis of the Nose
Journal of Craniofacial Surgery, 2017The authors present a clinical report of deforming mucocutaneous leishmaniasis of the nose in a native American woman, left untreated for 25 years. The nose was reconstructed using the local tissue displaced as flaps, and using cartilage grafts taken from the nasal septum and the ear shell.
Gian Luca, Gatti +7 more
openaire +2 more sources
Mucocutaneous leishmaniasis in a US citizen
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2003Mucocutaneous leishmaniasis (MCL) is endemic to many areas of Central and South America. A case of MCL in a US citizen is reported here. An ulcer appeared on the patient's left hard palate, years after a working trip to Peru. Punch biopsies of the lesion were obtained, Leishmania promastigotes were isolated by culture and animal inoculation, and the ...
Joseph W, Costa +2 more
openaire +2 more sources
American Mucocutaneous Leishmaniasis
Dermatologic Clinics, 1994American mucocutaneous leishmaniasis is produced by several species of Leishmania. The microorganism lives in jungle reservoirs and is transmitted by sandflies. After infection, a complex set of immunologic phenomena takes place. Most lesions tend to heal, but some clinical forms are relentlessly progressive and resistant to available therapy ...
openaire +2 more sources
Mucocutaneous leishmaniasis and AIDS: case report
Transactions of the Royal Society of Tropical Medicine and Hygiene, 1993In Perd tegumentary leishmaniases are endemic, more than 5000 new cases per year being reported by the Ministry of Health, although the estimated real incidence is three times as great, and human immunodeficiency virus (HIV) infections and the reported incidence of the acquired immune deficiency syndrome (AIDS) are increasing.
Echevarria Zarate, Juan Ignacio +6 more
openaire +3 more sources
Lingual Mucocutaneous Leishmaniasis
Acta Otorrinolaringologica (English Edition), 2021Cristina Isabel, Sanz Sánchez +2 more
openaire +2 more sources
Mucocutaneous Leishmaniasis Masquerading as Wegener Granulomatosis
JCR: Journal of Clinical Rheumatology, 2010A 43-year-old Brazilian female presented in 2001 with nasal stuffiness and sinusitis. A biopsy was consistent with limited Wegener's granulomatosis although antineutrophil cytoplasmic antibodies were negative. Her nasal inflammation progressed despite trials of prednisone, methotrexate, and azathioprine.
Ernest, Brahn +3 more
openaire +2 more sources

